IMNMImmunome, Inc.

28.52USD-4.38%Mkt Cap: 3.24B $P/E:

Immunome, Inc., a biotechnology company, engages in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics in the United States. The company d…